Established in September 2020, the EMBL Partnership Institute for Genome Editing Technologies at the Life Sciences Center adopts key elements of the European Molecular Biology Laboratory (EMBL) operational model, including scientific excellence, international recruitment, regular external evaluations, and strong support for early-career researchers, ensuring a dynamic and highly collaborative research environment.
The institute combines excellence in fundamental research with the ambition to translate discoveries into innovative tools and applications that benefit science, medicine, diagnostics, and agriculture.
The institute is committed to attracting and retaining outstanding international researchers by providing an inspiring and collaborative scientific environment, access to state-of-the-art research infrastructure, and networking opportunities across EMBL, its partner institutions and national collaborators, including the Vilnius University Faculty of Medicine, Santara Clinics, and other research and industry partners.
Strategic oversight and coordination of the partnership are provided by a joint Partnership Steering Committee comprising representatives from both EMBL and Vilnius University, ensuring the continued development of scientific excellence, international collaboration, and institutional growth.
Today, the Partnership Institute has developed into a vibrant international research environment, bringing together world-class principal investigators, postdoctoral fellows and PhD students.
Mission & Vision
Mission - to advance cutting-edge genome editing research by discovering, developing, and applying next-generation technologies that deepen our understanding of biological systems and enable transformative solutions for human health and biotechnology.
Vision - to be a world-leading center for genome editing innovation, translating fundamental discoveries into groundbreaking diagnostics, therapeutics, and biotechnological applications that improve lives globally.
About EMBL Partnership
About EMBL
Founded in 1974, the European Molecular Biology Laboratory (EMBL) is one of the world's leading research institutions in molecular biology. made EMBL Europe's flagship laboratory for the life sciences and one of the world's leading research organizations. Its mission is to uncover the molecular basis of life through pioneering research, technology development, and scientific training. EMBL brings together 29 member states and operates across six sites in Europe: Heidelberg, Hamburg, Grenoble, Hinxton, Rome, and Barcelona. It is the only intergovernmental organization in Europe dedicated exclusively to life sciences research.
About EMBL Partnership
The purpose of the EMBL Partnership is to strengthen scientific collaboration, facilitate the exchange of knowledge and expertise, and maximize the use of intellectual, technological, and research infrastructure resources. The partnership provides a strong framework for scientific excellence, international collaboration, and talent development. Through this collaboration, LSC contributes to advancing life sciences research while supporting the integration of the national research community into the broader European scientific landscape. The partnership creates a dynamic environment that encourage international collaboration, knowledge sharing and talent development.
Key Benefits of the EMBL Partnership:
- Collaboration with a world-leading life sciences institution.
- Global attraction of talents and scientific evaluation standards.
- Access to cutting-edge technologies and expertise.
- Outstanding training and career development opportunities.
- Enhanced international visibility and networking.